Is Spravato the Same as Ketamine

Understanding the difference between Spravato and ketamine is essential for anyone exploring modern treatments for depression. Although both medications come from the same family of drugs and impact similar pathways in the brain, they are not interchangeable, and each carries distinct advantages, limitations, and medical requirements.

Short Answer: Is Spravato the Same as Ketamine?

Quick Explanation

No, Spravato is not the same as ketamine. Spravato is a patented, FDA-approved nasal spray formulation of esketamine, while ketamine is an older, generic anesthetic used off-label for depression in infusion or injectable forms. They differ in formulation, approval status, administration method, monitoring rules, cost, and insurance coverage.

What Is Spravato? (EsKetamine)

How Spravato Works in the Brain

Spravato (esketamine) is a chemical subtype of ketamine known as the S-enantiomer, which binds more strongly to NMDA receptors. This interaction rapidly increases glutamate signaling, promoting synaptic growth and improving mood in ways traditional antidepressants cannot.

FDA Approval and Medical Indications

Spravato is one of the only fast-acting treatments approved specifically for depression. It is FDA-approved for:

• Treatment-resistant depression (TRD)

• Major depressive disorder with acute suicidal ideation or behavior

This makes it unique compared to regular ketamine, which is not FDA-approved for any psychiatric condition.

How It’s Administered (In-Clinic Protocols)

Spravato is self-administered via nasal spray inside a certified healthcare clinic, under direct supervision. Each session lasts about two hours, including:

• Dosing

• Vital monitoring

• Observation for dissociation or blood-pressure changes

Patients must arrange a ride home, driving afterward is prohibited.

Safety Requirements & Monitoring Guidelines

Due to its FDA Risk Evaluation and Mitigation Strategy (REMS) program:

• Spravato cannot be taken at home

• Only registered healthcare facilities can administer it

• Continuous monitoring is mandatory

These strict rules improve safety but increase cost and logistical complexity.

What Is Ketamine?

Types of Ketamine (Racemic Ketamine)

Traditional ketamine is racemic, meaning it contains both S-ketamine and R-ketamine. This broader mix may create different therapeutic effects than esketamine alone.

Medical Uses

Ketamine has been used for decades in:

• Anesthesia

• Pain management

• Emergency medicine

• Off-label depression treatment (most common via IV infusion)

Administration Methods

Clinics use several delivery formats:

• IV infusions (most researched for depression)

• IM injections

• Oral lozenges (usually part of at-home treatment plans)

Because ketamine is generic, it’s flexible and widely available.

Safety Considerations & Risks

Ketamine is generally safe under medical care but may cause:

• Dissociation

• Dizziness

• Nausea

• Blood-pressure elevation

• Short-term cognitive changes

Off-label clinics vary in quality, so choosing a reputable provider is essential.

Is Spravato the Same as Ketamine? (Core Explanation)

Key Differences: Is Spravato the Same as Ketamine?

While related, Spravato is chemically distinct, legally different, administered differently, regulated differently, and priced differently than ketamine.

Chemical Difference — EsKetamine vs Racemic Ketamine

• Spravato = esketamine only (S-enantiomer)

• Ketamine = both R- and S-enantiomers

The R-portion may play a unique antidepressant role, which Spravato does not include.

Legal & Regulatory Difference

• Spravato is FDA-approved for depression.

• Ketamine is only FDA-approved as an anesthetic; psychiatric use is off-label.

Potency and Pharmacology

Esketamine is roughly 2–4x more potent at NMDA receptor binding, but that doesn’t necessarily mean more effective — just differently active.

Differences in Research Evidence for Depression

Spravato’s approval is based on multiple controlled trials.
Ketamine’s depression research is broader, older, and includes thousands of patients but remains officially off-label.

Cost Differences

• Spravato: $4,000–$7,000 per month (before insurance)

• Ketamine: $300–$800 per infusion on average

Insurance Coverage Differences

• Spravato: Commonly covered when criteria are met

• Ketamine: Rarely covered for psychiatric use

Spravato vs Ketamine: Side Effects, Benefits, and Risks

Clinical Benefits Comparison

Both treatments rapidly improve depressive symptoms, often within hours. Spravato may offer more structured safety, while ketamine offers broader flexibility and potentially stronger and longer-lasting effects for some individuals.

Side Effects Comparison

Most common side effects include:

• Dissociation

• Dizziness

• Nausea

• Temporary blood pressure increases

Ketamine infusions may have slightly stronger dissociative effects due to higher absorbed doses.

Safety Protocols Comparison

• Spravato: Mandatory supervision, standardized safety

• Ketamine: Protocols vary by clinic

Who Each Option Is Best For

• Choose Spravato if you need insurance coverage or prefer FDA-approved treatments.

• Choose ketamine if you want IV infusion flexibility or access to R-ketamine’s potential benefits.

Step-by-Step Guide: How to Choose Between Spravato and Ketamine

Step 1 — Assess Your Diagnosis

Confirm whether you meet the criteria for TRD or MDD with suicidal ideation.

Step 2 — Evaluate Insurance Coverage

Spravato is widely covered; ketamine usually isn’t.

Step 3 — Consider Your Medical History

Your doctor will evaluate cardiovascular health, medications, and prior treatment failures.

Step 4 — Review Treatment Settings (Clinic vs. Infusion Center)

Spravato requires a REMS-certified clinic.
Ketamine can be administered in various clinic types.

Step 5 — Compare Expected Outcomes

Discuss onset speed, remission rates, and maintenance plans.

Step 6 — Discuss With a Certified Provider

Always consult a trained psychiatrist or ketamine specialist.

Step 7 — Plan for Monitoring & Follow-Up

Determine how often you’ll need sessions and long-term treatment planning.

Comparison Table: Spravato vs Ketamine

Feature	Spravato (Esketamine)	Ketamine (Racemic)
FDA Status	Approved for TRD & MDD w/ SI	Not approved for depression
Administration	Nasal spray	IV, IM, oral
Monitoring	Mandatory 2-hour observation	Varies by clinic
Mechanism	S-ketamine only	R- and S-ketamine
Cost	High, often covered	Lower, rarely covered
Duration of Effects	1–2 weeks	Days to weeks per infusion
Best For	Insurance-backed treatment	Flexible & lower-cost options